(Total Views: 1220)
Posted On: 09/14/2023 11:28:35 AM
Post# of 6857
UNVC: This here below tells you what a Lying Pumper of Univec Dalton is. He never delivers anything, just made-up fantasy deals, so he can keep selling his shares!!!
No UNVC products exist with either company, BR-MD lied to me telling me that the patches were in trials, and would be going to Drug Stores for marketing with several other private labeled products.
I guess this is just like the Enogenesis deal from back in Dec.2022 no products going anywhere
Univec, Inc. will make private label and bioRemedies MD products available through several
distribution channels, including the recently acquired mental health centers.
WHAT A WHOPPER THIS ONE IS FROM OCT 2018
David Dalton
CHAIRMAN,PRES,CEO at UNIVEC INC.
Univec Transdermal CBD Patch will have patient assistance programs including no cost
(patch is in partnership with Merck as per Merck VP of Global Western Markets Mr. John Peoples)
OVER (3) YEARS AGO
bioRemedies MD Delivers Enhanced CBD Formula
Through Patent-Pending Transdermal Patch to Treat
COVID-19. The patent-pending transdermal patch, developed in partnership with UNIVEC, seeks to relieve pain and inflammation and boost the immune system.
https://www.sec.gov/litigation/litreleases
https://www.sec.gov/whistleblower/submit-a-tip
https://www.sec.gov/tcr
https://www.sec.gov/oiea/Complaint.html
CHEERS
No UNVC products exist with either company, BR-MD lied to me telling me that the patches were in trials, and would be going to Drug Stores for marketing with several other private labeled products.
I guess this is just like the Enogenesis deal from back in Dec.2022 no products going anywhere
Univec, Inc. will make private label and bioRemedies MD products available through several
distribution channels, including the recently acquired mental health centers.
WHAT A WHOPPER THIS ONE IS FROM OCT 2018
David Dalton
CHAIRMAN,PRES,CEO at UNIVEC INC.
Univec Transdermal CBD Patch will have patient assistance programs including no cost
(patch is in partnership with Merck as per Merck VP of Global Western Markets Mr. John Peoples)
OVER (3) YEARS AGO
bioRemedies MD Delivers Enhanced CBD Formula
Through Patent-Pending Transdermal Patch to Treat
COVID-19. The patent-pending transdermal patch, developed in partnership with UNIVEC, seeks to relieve pain and inflammation and boost the immune system.
https://www.sec.gov/litigation/litreleases
https://www.sec.gov/whistleblower/submit-a-tip
https://www.sec.gov/tcr
https://www.sec.gov/oiea/Complaint.html
CHEERS
(7)
(0)Scroll down for more posts ▼
